Summary table assessment of the use of Alosetron hydrochloride (HCL), Ambrisentan, Bosentan, Buprenorphine HCL, Buprenorphine HCL/Naloxone HCL, Fentanyl, Hydromorphone HCL, Isotretinoin, Lenalidomide, Methadone HCL, Morphine sulfate, Oxycodone HCL, Rosiglitazone Maleate, Rosiglitazone/Glimepiride, Rosiglitazone/Metformin HCL, and Thalidomide. Results were generated using the Mini-Sentinel Distributed Query Tool and the Dispensing Summary Table.Summary tables are precompiled stratified counts. Queries were executed in September 2011. This report includes data from 15 Data Partners.
If you are using a web page screen reader and are unable to access this document, please use the Contact Us page for assistance or send an email requesting assistance to firstname.lastname@example.org.
The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.